Viscosupplementation Devices - Medical Devices Pipeline Product Landscape, 2021
Summary
GlobalData's Medical Devices sector report, “Viscosupplementation Devices - Medical Devices Pipeline Product Landscape, 2021 provides comprehensive information about the Viscosupplementation Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Viscosupplementation is the process by which the synovial fluid at the joints is replaced by a Hyaluronate preparation which has viscous properties similar to the natural synovial fluid. Viscosupplementation is used for the treatment of osteoarthritis of knee and other joints.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Viscosupplementation Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Viscosupplementation Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to BuyThe report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Viscosupplementation Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
- About GlobalData
- Introduction
- Viscosupplementation Devices Overview
- Products under Development
- Viscosupplementation Devices - Pipeline Products by Stage of Development
- Table Figure 1: Viscosupplementation Devices - Pipeline Products by Stage of Development
- Table Viscosupplementation Devices - Pipeline Products by Stage of Development
- Viscosupplementation Devices - Pipeline Products by Segment
- Table Figure 2: Viscosupplementation Devices - Pipeline Products by Segment
- Table Viscosupplementation Devices - Pipeline Products by Segment
- Viscosupplementation Devices - Pipeline Products by Territory
- Table Figure 3: Viscosupplementation Devices - Pipeline Products by Territory
- Table Viscosupplementation Devices - Pipeline Products by Territory
- Viscosupplementation Devices - Pipeline Products by Regulatory Path
- Table Figure 4: Viscosupplementation Devices - Pipeline Products by Regulatory Path
- Table Viscosupplementation Devices - Pipeline Products by Regulatory Path
- Viscosupplementation Devices - Pipeline Products by Estimated Approval Date
- Table Figure 5: Viscosupplementation Devices - Pipeline Products by Estimated Approval Date
- Table Viscosupplementation Devices - Pipeline Products by Estimated Approval Date
- Viscosupplementation Devices - Ongoing Clinical Trials
- Table Figure 6: Viscosupplementation Devices - Ongoing Clinical Trials
- Table Viscosupplementation Devices - Ongoing Clinical Trials
- Viscosupplementation Devices - Pipeline Products under Development by Companies
- Viscosupplementation Companies - Pipeline Products by Stage of Development
- Table Viscosupplementation Companies - Pipeline Products by Stage of Development
- Viscosupplementation Devices - Companies Pipeline Products by Stage of Development
- Table Viscosupplementation Devices - Companies Pipeline Products by Stage of Development
- Viscosupplementation Companies and Product Overview
- Ampio Pharmaceuticals Inc Company Overview
- Ampio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table Ampio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table Ampion - Product Status
- Table Ampion - Product Description
- Table Ampion - Hand Osteoarthritis - Product Status
- Table Ampion - Hand Osteoarthritis - Product Description
- Table Ampio Pharmaceuticals Inc - Ongoing Clinical Trials Overview
- Table Ampion - A Randomized, Controlled, Double-blind Study to Evaluate the Efficacy and Safety of an Intra-articular Injection of Ampion in Adults with Pain Due to Severe Osteoarthritis of the Knee
- Table Ampion - A Randomized, Double-blinded, Placebo Controlled Phase II Study to Evaluate the Safety and Efficacy of IV Ampion in Adult COVID-19 Patients Requiring Oxygen Supplementation
- Anika Therapeutics Inc Company Overview
- Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table Cingal - Product Status
- Table Cingal - Product Description
- Table Hyaluronic Acid - Synovial Joints - Product Status
- Table Hyaluronic Acid - Synovial Joints - Product Description
- Table MONOVISC - Hip - Product Status
- Table MONOVISC - Hip - Product Description
- Table ORTHOVISC-T - Product Status
- Table ORTHOVISC-T - Product Description
- Table Sodium Hyaluronate - Osteoarthritis - Product Status
- Table Sodium Hyaluronate - Osteoarthritis - Product Description
- Table Anika Therapeutics Inc - Ongoing Clinical Trials Overview
- Table Cingal - A Prospective Evaluation of the Cingal Injection for Hip Osteoarthritis (ECHO Study)
- Table Cingal - A Prospective Study of a Single Injection Cross-linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (CINGAL) to Provide Symptomatic Relief of Osteoarthritis of Ankle Joint
- Table Cingal - A Prospective Study of a Single Injection Cross-linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (CINGAL) to Provide Symptomatic Relief of Osteoarthritis of Hip Joint
- Table Cingal - A Prospective Study of a Single Injection Cross-linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (CINGAL) to Provide Symptomatic Relief of Osteoarthritis of Shoulder Joint
- Bone Therapeutics SA Company Overview
- Bone Therapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
- Table Bone Therapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
- Table JTA-004 - Product Status
- Table JTA-004 - Product Description
- Table Bone Therapeutics SA - Ongoing Clinical Trials Overview
- Table JTA-004 - A Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis
- Carticept Medical Inc Company Overview
- Carticept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table Carticept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table Agilus - Product Status
- Table Agilus - Product Description
- Chi2Gel Ltd. Company Overview
- Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
- Table Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
- Table Chi2Knee - Product Status
- Table Chi2Knee - Product Description
- Cocoon Biotech, Inc. Company Overview
- Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- Table Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- Table Silk Hydrogel - Product Status
- Table Silk Hydrogel - Product Description
- Flex Biomedical Inc Company Overview
- Flex Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table Flex Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table Flex Polymer - Product Status
- Table Flex Polymer - Product Description
- Herng Shan Co Ltd Company Overview
- Herng Shan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table Herng Shan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table Hyalease 16 and 20 - Product Status
- Table Hyalease 16 and 20 - Product Description
- Table Hyalease 8 - Product Status
- Table Hyalease 8 - Product Description
- Kalvista Pharmaceuticals Inc Company Overview
- Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table ActaVisc - Product Status
- Table ActaVisc - Product Description
- Table Hydros - Product Status
- Table Hydros - Product Description
- Table Hydros TA - Product Status
- Table Hydros TA - Product Description
- Table Hydros TA - Hip - Product Status
- Table Hydros TA - Hip - Product Description
- KiOmed Pharma Company Overview
- KiOmed Pharma Pipeline Products & Ongoing Clinical Trials Overview
- Table KiOmed Pharma Pipeline Products & Ongoing Clinical Trials Overview
- Table Arthrovisc - Product Status
- Table Arthrovisc - Product Description
- Lineage Cell Therapeutics Inc Company Overview
- Lineage Cell Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table Lineage Cell Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table ReGlyde - Product Status
- Table ReGlyde - Product Description
- Medytox Inc Company Overview
- Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table MT941 - Product Status
- Table MT941 - Product Description
- Moebius Medical Ltd Company Overview
- Moebius Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table Moebius Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table MM-II - Product Status
- Table MM-II - Product Description
- Table Moebius Medical Ltd - Ongoing Clinical Trials Overview
- Table MM-II - A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Single-administration, Multiple-Dose Study to Demonstrate the Efficacy and Safety of MM-II for Treatment of Knee Pain in Subjects with Symptomatic Knee Osteoarthritis
- Oligo Medic Inc Company Overview
- Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table JointVisc - Product Status
- Table JointVisc - Product Description
- OPKO Health Inc Company Overview
- OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table Enko 1 - Product Status
- Table Enko 1 - Product Description
- Orchestra BioMed Inc Company Overview
- Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table SirolimusEFR Intra-Articular Injection - Product Status
- Table SirolimusEFR Intra-Articular Injection - Product Description
- Prohibix LLC Company Overview
- Prohibix LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table Prohibix LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table Hyalease Hydrogel Microparticle - Product Status
- Table Hyalease Hydrogel Microparticle - Product Description
- Rottapharm Biotech Srl Company Overview
- Rottapharm Biotech Srl Pipeline Products & Ongoing Clinical Trials Overview
- Table Rottapharm Biotech Srl Pipeline Products & Ongoing Clinical Trials Overview
- Table PVA Hydrogel - Product Status
- Table PVA Hydrogel - Product Description
- Seikagaku Corp Company Overview
- Seikagaku Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table Seikagaku Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table JOYCLU 30mg Intra-Articular Injection - Product Status
- Table JOYCLU 30mg Intra-Articular Injection - Product Description
- Table SI-613 - Enthesopathy - Product Status
- Table SI-613 - Enthesopathy - Product Description
- Shin Poong Pharm Co Ltd Company Overview
- Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table HyalOne - Product Status
- Table HyalOne - Product Description
- University of Kansas Company Overview
- University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
- Table University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
- Table 3-D Colloidal Gel - Product Status
- Table 3-D Colloidal Gel - Product Description
- Viscosupplementation- Recent Developments
- Nov 09, 2021: Bioventus Reports Third Quarter Results Updates Full-Year 2021 Financial Guidance
- Nov 04, 2021: Anika Reports Third Quarter 2021 Financial Results
- Nov 01, 2021: Anika Appoints Sheryl Conley to Board of Directors
- Oct 18, 2021: Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021
- Sep 07, 2021: Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
- Aug 10, 2021: Bioventus Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance
- Jul 29, 2021: Smith+Nephew Second Quarter and First Half 2021 Results
- Jul 29, 2021: Bioventus Reports Preliminary Second Quarter Net Sales and Updates Full-Year 2021 Net Sales Guidance
- Jul 29, 2021: Smith & Nephew announces Half-year Report
- Jul 19, 2021: Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021
- Jul 14, 2021: Bioventus Appoints Mary Kay Ladone to Board of Directors
- Jul 07, 2021: Timing of Smith+Nephew Second Quarter Trading and First Half 2021 Results
- Jun 16, 2021: Bioventus to Release Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021
- May 17, 2021: Bioventus Senior Management to Present at Upcoming Investor Conferences
- May 13, 2021: Anika to Host its 2021 Virtual Investor Day on June 3, 2021
- May 12, 2021: Bioventus Reports First Quarter Results; Updates Full Year 2021 Financial Guidance
- May 03, 2021: KalVista Pharmaceuticals Expands Senior Leadership Team with Appointment of Paul K. Audhya, MD, MBA as Chief Medical Officer
- Apr 05, 2021: Anika to Participate in the 20th Annual Needham Virtual Healthcare Conference
- Mar 19, 2021: KalVista Pharmaceuticals appoints Nancy Stuart to Board of Directors
- Mar 11, 2021: Anika to Participate in the Sidoti Spring Virtual Investor Conference
- Mar 04, 2021: Larry Chen Joins Bioventus as Managing Director China and Asia Pacific
- Mar 04, 2021: Anika Reports Fourth Quarter and Year-End 2020 Financial Results
- Mar 01, 2021: Bioventus to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 25, 2021
- Feb 18, 2021: KalVista Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference
- Feb 18, 2021: Smith+Nephew Fourth Quarter and Full Year 2020 Results
- Feb 18, 2021: D.C. CFO Jeffrey DeWitt to resign next month amid pandemic-tinged budget season
- Jan 21, 2021: OrthogenRx announces 2020 achievements
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer